-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Immucell Corp /De/ quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Immucell Corp /De/ Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $1.34K, a 12.1% decline year-over-year.
- Immucell Corp /De/ Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $4.26K, a 49.5% decline year-over-year.
- Immucell Corp /De/ annual Income Tax Expense (Benefit) for 2023 was $4.63K, a 39.7% decline from 2022.
- Immucell Corp /De/ annual Income Tax Expense (Benefit) for 2022 was $7.67K, a 16.3% decline from 2021.
- Immucell Corp /De/ annual Income Tax Expense (Benefit) for 2021 was $9.17K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)